Anemia: Prevalence, Risk Factors and Management Strategies

Alice Hallman (Editor)

Series: Recent Advances in Hematology Research
BISAC: MED038000

Clear

$192.00

Volume 10

Issue 1

Volume 2

Volume 3

Special issue: Resilience in breaking the cycle of children’s environmental health disparities
Edited by I Leslie Rubin, Robert J Geller, Abby Mutic, Benjamin A Gitterman, Nathan Mutic, Wayne Garfinkel, Claire D Coles, Kurt Martinuzzi, and Joav Merrick

eBook

Digitally watermarked, DRM-free.
Immediate eBook download after purchase.

Product price
Additional options total:
Order total:

Quantity:

Browse Wishlist
Browse Wishlist

Details

Anemia is defined as the decrease in hemoglobin from normal values either by loss of red blood cells or deficit in production or both. Hemoglobin is the major transporter of oxygen. The variation in hemoglobin is therefore a factor in determining the cardiac output. This book begins by discussing the effects anemia has on heart diseases.

The book then continues to discuss the influence of iron deficiency anemia and recovery on oxidative/antioxidant status; influence of iron deficiency anemia on bone metabolism; sickle cell anemia; anemia in myelodysplastic syndromes; transfusion in chronic anemia; the prevalence, risk factors and management with a focus on chronic kidney disease; strategy for treating anemia in chronic kidney disease patients from the standpoint of iron utility; and parasitic anemia (Imprint: Nova Biomedical)

Preface

Chapter 1 - Anemia in Heart Diseases (pp. 1-18)
Estelle Torbey, M.D. and Gretta Torbey, M.D. (Staten Island University Hospital, New York, USA, and others)

Chapter 2 - Influence of Iron Deficiency Anaemia and Recovery on Oxidative/Antioxidant Status (pp. 19-34)
Javier Díaz-Castro, Mario Pulido-Moran, Silvia Hijano, Naroa Kajarabille and Julio J. Ochoa (Institute of Nutrition and Food Technology “José Mataix Verdú”. Biomedical Research Center. Health Sciences Technological Park. University of Granada, Granada, Spain, and others)

Chapter 3 - Influence of Iron Deficiency Anaemia on Bone Metabolism (pp. 35-48)
Javier Díaz-Castro, Silvia Hijano, Mario Pulido-Moran, Naroa Kajarabille and Julio J. Ochoa (Institute of Nutrition and Food Technology “José Mataix Verdú”. Biomedical Research Center. Health Sciences Technological Park. University of Granada, Granada, Spain, and others)

Chapter 4 - Sickle Cell Anemia: Prevalence, Risk Factors and Management Strategies (pp. 49-64)
Bruna Miglioranza Scavuzzi, Lucia Helena da Silva Miglioranza and Isaias Dichi (Health Sciences Doctoral Student - University of Londrina, Londrina, Parana, Brazil, and others)

Chapter 5 - Anemia in Myelodysplastic Syndromes (pp. 65-98)
Alicia Enrico, M.D., María Gabriela Flores, M.D., Laura Kornblihtt, M.D., Ph.D., Elsa Nucifora, M.D., Yesica Bestach, M.Sc., Irene B. Larripa, Ph.D., and Carolina B. Belli, Ph.D. (Área de Hematología, Hospital Italiano, La Plata, Servicio de Hematología, Hospital General de Agudos “C Durand”, Buenos Aires, and others)

Chapter 6 - Transfusion in Chronic Anaemia (pp. 199-122)
Philip Crispin (Haematologist, Canberra Hospital, Lecturer, Australian National University Medical School, Honorary Clinical Fellow, Australian Red Cross Blood Service)

Chapter 7 - Anaemia: Prevalence, Risk Factors and Management with a Focus on Chronic Kidney Disease (pp. 123-146)
K. Abdul Razak, D.W. Mudge and D. W. Johnson (Department of Nephrology, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Queensland, Australia, and others)

Chapter 8 - Strategy for Treating Anemia in Chronic Kidney Disease Patients from the Standpoint of Iron Utility (pp. 147-164)
Daisuke Harada, Takehisa Kawata and Masaaki Inaba (Nephrology Research Laboratories, Nephrology R&D Unit, R&D Division, Kyowa Hakko Kirin Co., Ltd., and others)

Chapter 9 - Parasitic Anemia: Prevalence, Risk and Management (pp. 165-170)
Somsri Wiwanitkit and Viroj Wiwanitkit (Wiwanitkit House, Bangkhae, Bangkok Thailand, and others)

Index

You have not viewed any product yet.